INMED PHARMACEUTICALS INC

Historical 13F Holders

Reported Value, Excluding Options

Total Filings

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 457637700 since 12/18/2024, largest first.

Filer	% of Class	Shares	Form	Filed
Vivo Opportunity Fund Holdings, L.P. 13D	21.7%	718,444	13D	6/10/2026 Event 5/19/2026
Vivo Opportunity Fund Holdings, L.P.	21.7%	718,444
Vivo Opportunity, LLC	21.7%	718,444
Vivo Opportunity Cayman Fund, L.P.	2.2%	72,535
Vivo Opportunity Cayman, LLC	2.2%	72,535
ADAR1 Capital Management, LLC 13G/A	17.2%	943,668	13G/A	10/7/2026 Event 9/30/2026
ADAR1 Capital Management, LLC	17.2%	943,668
Daniel Schneeberger	17.2%	943,668
Sabby Management, LLC 13G	9.9%	280,138	13G	1/20/2026 Event 12/31/2025
Sabby Management, LLC	9.9%	280,138
Hal Mintz	9.9%	280,138
Sabby Volatility Warrant Master Fund, Ltd.	9.9%	280,138
Squadron Capital Management LLC 13G	9.8%	325,000	13G	5/27/2026 Event 5/19/2026
Squadron Master Fund LP	9.8%	325,000
Squadron Capital Management LLC	9.8%	325,000
Matthew Sesterhenn	9.8%	325,000
William Blank	9.8%	325,000
Under 5%, checked the "5 percent or less" box, or amended by a later filing (1)
Ikarian Capital, LLC 13G	4.2%	137,634	13G	8/14/2026 Event 6/30/2026
Ikarian Capital, LLC	4.2%	137,634
Neil Shahrestani	4.2%	137,634

Period	Filings	Shares, Excl. Options	Value, Excl. Options	Options Value
2026 Q2	20	2.70 M	$5.18 M	$0
2026 Q1	9	319 k	$206 k	$0
2025 Q4	7	227 k	$241 k	$0
2025 Q3	9	304 k	$665 k	$0
2025 Q2	8	8.47 k	$28.5 k	$0
2025 Q1	6	6.41 k	$13.3 k	$0
2024 Q4	6	48.9 k	$227 k	$0